-- European Heart Rhythm Association (EHRA)
-- European Primary Care Cardiovascular Society (EPCCS)
-- European Stroke Organisation (ESO)
-- European Stroke Conference
-- German Competence Network on Atrial Fibrillation (AFNET)
-- International Council of Nurses (ICN)
-- Italian Atherosclerosis, Thrombosis and Vascular Biology (ATBV) Working Group
-- Sociedad Española de Neurologia (Spanish Neurological Association)
-- StopAfib.org
-- World Stroke Organization (WSO)
La alianza Action for Stroke Prevention está patrocinada por Bayer Schering Pharma AG.
Referencias
[1] Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008;92:17-40
[2] Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The
Framingham Study. Arch Intern Med 1987;147:1561-4
[3] Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population based study. Stroke 2005;36:1115-19
[4] Wolfe CD. The impact of stroke. Br Med Bull 2000;56:275-86
[5] White CL, Poissant L, Cote-LeBlanc G, et al. Long-term caregiving after stoke: the impact on caregivers' quality of life. J Neurosci Nurs 2006;38:354-60
[6] Allender S, Scarborough P, Peto V et al. European cardiovascular disease statistics 2008 edition. http://www.heartstats.org/uploads/documents%5Cproof30NOV2007.... Accessed November 2009
[7] Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5
[8] Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25
[9] Briffa T, Hickling S, Knuiman M, et al. Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ 2009;338:b36
[10] Kirchhof et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on AF entitled 'Research perspectives in AF', EurHJ 2009
[11] World Health Organization. The global burden of disease: 2004 update. http://www.who.int/healthinfo/global_burden_disease/2004_rep.... Accessed November 2009
[12] Truelsen T, Piechowski-Jozwiak B, Bonita R et al. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13:581-98
[13] Lamassa M, Di Carlo A, Pracucci G et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital based registry (The European Community Stroke Project). Stroke 2001;32:392-8
[14] Bruggenjurgen B, Rossnagel K, Roll S et al. The impact of atrial fibrillation on the cost of stroke: the Berlin acute stroke study. Value Health 2007;10: 137-43
[15] Health-EU: Cardiovascular disorders. http://ec.europa.eu/health-eu/health_problems/cardiovascular.... Accessed November 2009
[16] NHS Choices. Atrial fibrillation. 2007 http://www.nhs.uk/Conditions/Atrial-fibrillation Accessed November 2009
[17] Olsson SB, Helperin J. Prevention of stroke in patients with atrial fibrillation. Seminars in Vascular Medicine 2005;5(3):285-92
(Debido a la longitud de las URL superiores, puede ser necesario copiar y pegar estos hipervínculos en el campo de la dirección URL del navegador de Internet. Elimine espacios si los hubiera).
Contactos: Lucy Yeatman, lyeatman@ruderfinn.co.uk, T: +44-20-7462-8957; Wioletta Niznik, wniznik@ruderfinn.co.uk, T: +44-20-7462-8913
